We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
(+9.1%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$35.4M |
| 2 |
P
Everpure Inc
P
|
+$21M |
| 3 |
NVIDIA
NVDA
|
+$20.7M |
| 4 |
American Homes 4 Rent
AMH
|
+$19.3M |
| 5 |
DAY
Dayforce
DAY
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$46.7M |
| 2 |
Apple
AAPL
|
+$41.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$32.3M |
| 4 |
Gilead Sciences
GILD
|
+$27.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.42% |
| 2 | Financials | 13.09% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.52M | ﹤0.01% |
299,749
+5,098
| +2% | +$28.7K |
|
2027
Lennar Class B
LEN.B
$20.2B
| $1.52M | ﹤0.01% |
10,358
-1,025
| -9% | -$139K |
|
2028
Alkami Technology
ALKT
$2.1B
| $1.52M | ﹤0.01% |
61,730
+1,268
| +2% | +$31.1K |
|
2029
Coca-Cola Femsa
KOF
$22.9B
| $1.52M | ﹤0.01% |
15,597
+1,276
| +9% | +$122K |
|
2030
Sabesp
SBS
$18.3B
| $1.51M | ﹤0.01% |
462,385
-9,530
| -2% | -$29.1K |
|
2031
United Fire Group
UFCS
$1.37B
| $1.49M | ﹤0.01% |
68,649
-789
| -1% | -$17.5K |
|
|
HAPN
2032
Happen Inc
HAPN
$2.24B
| $1.49M | ﹤0.01% |
169,756
+4,529
| +3% | +$38K |
|
2033
Skyward Specialty Insurance
SKWD
$2.51B
| $1.49M | ﹤0.01% |
39,832
+6,811
| +21% | +$230K |
|
2034
Energy Fuels
UUUU
$3.57B
| $1.49M | ﹤0.01% |
236,829
-50,291
| -18% | -$339K |
|
2035
Methode Electronics
MEI
$581M
| $1.49M | ﹤0.01% |
122,150
-90,412
| -43% | -$1.71M |
|
2036
Corsair Gaming
CRSR
$1.48B
| $1.49M | ﹤0.01% |
120,382
+66
| +0.1% | +$858 |
|
2037
IES Holdings
IESC
$15B
| $1.48M | ﹤0.01% |
12,203
+399
| +3% | +$38.2K |
|
2038
Honda
HMC
$41.2B
| $1.48M | ﹤0.01% |
39,819
+1,837
| +5% | +$63.1K |
|
|
DAWN
2039
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.48M | ﹤0.01% |
89,727
+2,293
| +3% | +$34.3K |
|
2040
Blue Bird Corp
BLBD
$2.07B
| $1.48M | ﹤0.01% |
38,593
+3,045
| +9% | +$93.2K |
|
2041
Energy Recovery
ERII
$408M
| $1.48M | ﹤0.01% |
93,666
+5,555
| +6% | +$88.4K |
|
2042
Herbalife
HLF
$1.21B
| $1.48M | ﹤0.01% |
147,104
+3,849
| +3% | +$41.4K |
|
|
BRSP
2043
BrightSpire Capital
BRSP
$620M
| $1.47M | ﹤0.01% |
213,360
+12,031
| +6% | +$84.1K |
|
2044
Fulgent Genetics
FLGT
$524M
| $1.47M | ﹤0.01% |
67,573
+1,027
| +2% | +$25.5K |
|
2045
Claros Mortgage Trust
CMTG
$250M
| $1.46M | ﹤0.01% |
150,070
+3,020
| +2% | +$32.7K |
|
2046
UBS Group
UBS
$177B
| $1.46M | ﹤0.01% |
47,643
| – | – |
|
2047
Rio Tinto
RIO
$166B
| $1.46M | ﹤0.01% |
22,910
+3,957
| +21% | +$265K |
|
2048
Globalstar
GSAT
$10.9B
| $1.46M | ﹤0.01% |
66,223
+2,003
| +3% | +$48.5K |
|
2049
MiMedx Group
MDXG
$622M
| $1.46M | ﹤0.01% |
189,288
+2,669
| +1% | +$21.5K |
|
2050
Movado Group
MOV
$817M
| $1.46M | ﹤0.01% |
52,162
-781
| -1% | -$21.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
- RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
- RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
- RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
- RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
- RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
- RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.
Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.